Summary. Olycosylated haemoglobin (HbAI) was measured serially by microcolumn chromatography in 38 children with newly diagnosed insulin-dependent diabetes. Initial HbA~ levels of 13.6 + 0.5% fell significantly from day 0 (prior to therapy) both to day 1 (1.6 _+ 0.2% decrease) and to day 3-5 (2.6 + 0.4% decrease) (p < 0.001). This drop correlated closely with changes in blood glucose (p < 0.001), less closely and inversely with plasma bicarbonate levels (p < 0.01), but not with prior duration of symptoms or changes in serum cholesterol and triglyceride concentrations. HbA1 levels reached a nadir of 8.2 + 0.3% 3 weeks to 6 months after diagnosis, and correlated with decreasing insulin dosage (p < 0.001). HbA~ levels rose again to 11.4 + 0.5% in 21 patients followed for more than 3-6 months. Our results indicate that (1) HbA 1 levels change rapidly during initial stabilization of insulin-dependent diabetes suggesting that glycosylation may not be entirely irreversible, and (2) HbA 1 levels are consistent with clinical assessment of control during remission and postremission phases.
Glycosylation of haemoglobin is thought to be a posttranscriptional reaction that is slow, non-enzymatic and largely irreversible [1, 2] . In patients with diabetes mellitus glycosylated haemoglobin (HbA0 levels are significantly elevated and are felt to reflect fairly accurately the integrated glucose concentrations over the previous 2 months [3] [4] [5] [6] [7] . However, some workers report poor correlation between clinical ratings of diabetic control and HbA 1 levels, allowing only separation of excellently and very badly controlled diabetics [8, 9] . Some recent data suggests that part of the HbA 1 fraction is formed by a fast reversible process [9, 10] . Therefore, acute swings in blood glucose, a common finding in diabetics, could produce changes in HbA1 and thereby invalidate the assumption that HbA1 levels represent long-term control.
Our study was designed to assess HbA1 levels at frequent intervals in children with newly diagnosed insulin-dependent diabetes mellitus (IDD) during the initial stabilization and remission phases. This has enabled us to evaluate the degree of variation of HbA1 over a short period.
Patients and Methods
Thirty-eight children aged 4 to 17 years with newly diagnosed IDD were studied. There were 18 girls and 20 boys. On admission 17 of the patients were ketoacidotic, 13 ketotic only and 8 were neither ketotic nor acidotic. Two of the patients were severely hyperosmolar with only mild to moderate ketoacidosis. The duration of symptoms prior to diagnosis ranged from 2 days to 16 weeks. Two patients had Hashimoto's thyroiditis, one of whom was diagnosed previously and was receiving L-thyroxine 0.1 mg once daily. In the other, hypothyroidism was diagnosed at the time of initial presentation of IDD. A further patient was found to be thyrotoxic at presentation and has subsequently received propylthiouracil. None of the children received blood transfusions at any time.
Blood samples were obtained on admission prior to the administration of insulin (day 0) for measurement of blood glucose levels, acid-base and electrolyte balance, serum lipid levels and HbAv These measurements were repeated on a fasting specimen on the following day (day 1), and on days 3 and/or 5. At each clinic visit thereafter (2-3 weeks, 2-4 months, 6-8 months and 9-12 months) postprandial blood was sampled in all patients for glucose, cholesterol and HbA 1 measurements.
HbA 1 was measured by column chromatography using the Quik-Sep microcolumn (Isolab Incorporated, Akron, Ohio) in a laboratory with a stable temperature of 23-24 ~ The mean HbA 1 of 75 normal children was 6.1 _+ 0.6% (mean _+ SD). Intra-and 0012-186X/80/0019/0423/$01.00 interassay coefficients of variation were 2 and 6% respectively. Glucose was measured by a glucose oxidase method using a YSI (Yellow Springs) analyser. Triglycerides were measured in plasma after extraction by the method of Levy [12] . Cholesterol was measured by the method of Zak [13] . The data were analyzed by simple analysis of variance, Student's t-test for paired means, linear regression analysis and Spearman's rank-order correlation coefficient where applicable. Results are expressed as mean _+ SEM.
Results
Glycosylated Haemoglobin (HbA1) Levels (Fig. 1 ) At diagnosis the mean HbA1 level was 13.6 _+ 0.5% which was significantly above normal. There was a highly significant decrease of HbA 1 levels of 2.6 +_ 0.4% during the first 3-5 days in hospital to 11.0 _+ 0.4% (p < 0.001). The fall was most striking from day 0 to day 1 (1.6 _+ 0.2%). The decrease from day 1 to day 3-5, although significant (p < 0.05), was smaller than the initial fall. In the 29 patients followed more than one month HbA1 reached a nadir of 8.2 + 0.3%. This nadir occurred between 2-8 weeks in 15 patients, 2-4 months in 13 and after 4 months in one. In 25 of these 29 children, HbA1 levels fell below 10% with 11 values within the normal range. The fall in HbA1 levels correlated closely with decreasing insulin dosage characteristic of the remission phase (p < 0.0001). The mean daily insulin dosage at the time of discharge was 0.72 + 0.04U/kg. At the time of the HbA~ nadir, this had fallen to 0.32 _+ 0.04 U/kg. In all 21 patients followed for more than 3 to 6 months, HbA1 levels were found to increase again, reaching values of 11.4 +_ 0.5%. This rise was noted between 3-6 months in 9 children, 6-9 months in 8 and after 9 months in four. It frequently occurred before or during the period of rapidly increasing insulin dosage. The mean insulin dosage at this time was 0.59 _+ 0.04 U/kg, significantly greater than that at the time of the HbA1 nadir (p < 0.001). Figure 2 depicts the highly significant correlation between the changes in both HbA 1 and glucose values over the first 24 hours in hospital (r = 0.65, p < 0.001). A similar correlation was found between both the initial HbA1 level and its fall and the initial glucose values (r = 0.60, p < 0.001, and r = 0.47, p < 0.01 respectively). There was no correlation between the initial HbA1 or its fall with either the previous duration of symptoms or with changes in serum cholesterol and triglyceride levels during the first five days of therapy. There was an inverse correlation between the fall in HbA1 levels and the initial plasma bicarbonate concentration (r = -0.45, p < 0.01).
Correlation of HbAj Levels with Blood Glucose and Lipids
The two children with the highest initial HbA1 levels (21.7 and 18.4% respectively) also showed the largest decrements in HbA1 over the first 3 days in hospital (decrease of 6.1 and 8.8% respectively). These two patients had in common very severe hyperglycaemia and hyperosmolarity with only mild tO moderate ketoacidosis.
Results of tests during the first year after diagnosis, during both the remission and post-remission phases, showed a correlation between HbA 1 levels and 1-2 hour postprandial blood glucose measurements (n = 88, r = 0.52, p < 0.001). There was a similar correlation between HbA 1 levels and 24 h glycosuria measured in a specimen collected in the week prior to a clinic visit (n = 48, r = 0.53, p < 0.001). There was no correlation between HbA1 levels and serum cholesterol values during this period. Of note is the very significant correlation that existed between HbA1 levels and insulin dosage at each visit (n = 76, r ---0.52, p < 0.001).
Discussion
These results show that glycosylated haemoglobin is increased in all children with newly diagnosed IDD and correlates with the degree of hyperglycaemia, but not with its duration as assessed by prior symptoms. Using a column method there is a highly significant fall in HbA 1 levels during the initial 5 day stabilization phase in hospital particularly during the first 24 hours. This represents a previously unreported finding in newly diagnosed diabetics. Because the degree of hyperglycaemia and decreased bicarbonate concentration are probably related to the severity of the metabolic disorder, their respective correlations with changes in HbA~ levels might simply reflect their interdependence.
The high HbA 1 levels at diagnosis confirm previous reports in maturity onset diabetes [14, 15] and much smaller groups of children with IDD [16] . In these studies HbA1 levels were not noted to fall significantly although in none were measurements made as frequently as in our study. Fraser et al. [14] found the highest HbA 1 concentrations in patients with maturity onset diabetes with glycaemic symptoms of long duration and high plasma glucose concentrations at diagnosis. Ditzel and Kjaergaard [15] reported that a return to normal or near normal values took 25-80 days depending on initial HbA l levels and degree of control. Our study confirms this latter finding with HbA1 levels reaching a nadir 3 weeks to 6 months after diagnosis. Paulsen and Koury [16] showed raised HbA1 levels in four newly diagnosed children in acidosis that were not altered with correction of acidosis or regulation of the diabetic state over the next 7-10 days. On the other hand, Karamanos et al. [10] suggested that changes in HbA~ can be found over three to four day intervals in parallel with changes in diabetic control in 10 patients with IDD. Svendsen et al. [9] were able to alter HbA1 levels acutely both in vivo, by means of control of blood glucose by an artificial pancreas (GCIIS, Biostator), and in vitro, by incubation of whole blood in saline with and without added glucose. Also using the GCIIS, Bolli et al. [11] found similar acute falls in HbA1 levels during a 3 day period in 11 patients with IDD in varying degrees of metabolic control.
The reason for the fall in HbA 1 remains uncertain. In patients with diabetes mellitus, glycosylation of haemoglobin occurs predominantly at the N-terminus of the fl-chain to produce the two-to threefold elevations of HbAlc [2] . This reaction occurs first by means of a Schiff base that undergoes an Amadori rearrangement forming an essentially irreversible ketoamine linkage. The first step, the aldimine modification, may be easily reversible. In addition, glucose may bind to other residues in both a and fl chains. These reactions do not produce chromatographically separable minor components [1, 5] . It has been suggested that glucose may bind non-specifically and reversibly to these sites [5] . This may account for the highly significant reversible component noted in our column study which was closely correlated with changes in blood glucose levels.
Our findings in children with IDD confirm the fall of HbA1 levels during the weeks to months following institution of insulin therapy reported in adult diabetics [14, 15] . In children the decreasing HbA 1 reflects the improved carbohydrate tolerance noted during the honeymoon phase when insulin dosage decreases markedly and stability is relatively easily achieved. Increasing HbA1 levels noted at the end of the remission phase in our patients followed for longer than three to six months are consistent with the declining carbohydrate tolerance as demonstrated by rising insulin requirements. This suggests that a rising HbA~ may serve as a signal to further increase insulin requirement before the patient is symptomatically hyperglycaemic.
After stabilization the close correlation between HbA1 levels with random blood glucose values and 24 hour glycosuria, provides further evidence that HbA~ estimation is a valuable adjunct in the assessment of diabetic control.
This study highlights the role of HbA 1 in newly diagnosed diabetic children and should provide further impetus to the better characterization of the glycosylation process.
